CD4 and COVID-19: This suggests a chronic inflammatory response, a trend observed in patients experiencing more severe COVID-19 progression.18,20 Variations in the CD4/CD8 ratio between the two groups have been a topic of continued research, with prior findings highlighting similar tendencies towards either hyperimmune reactions or immunosuppression.